Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Annals of Pharmacotherapy|December 4, 2019
Selinexor: A First-in-Class Nuclear Export Inhibitor for Management of Multiply Relapsed Multiple MyelomaTim J Peterson, Jennifer Orozco, Michael Buege
Science (New York, N.Y.)|May 14, 2021
Watersheds may not recover from droughtTim J Peterson, M Saft, M C Peel, et al.
Scientific Reports|June 15, 2023
Seasonal estimation of groundwater vulnerabilityAdrian I Cervantes-Servin, Meenakshi Arora, Tim J Peterson, et al.
The Annals of Pharmacotherapy|January 7, 2017
Venetoclax: A First-in-Class Oral BCL-2 Inhibitor for the Management of Lymphoid MalignanciesAmber C King, Tim J Peterson, Troy Z Horvat, et al.
Pharmacotherapy|August 19, 2018
Current and Investigational Agents Targeting the Phosphoinositide 3-Kinase PathwayLaura A Tang, Brianne N Dixon, Kathryn T Maples, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 20, 2021
IVAC With or Without Rituximab for Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas: Real-World Experience in the Modern EraMichael J Buege, Phuong H Dao, Esther Drill, et al.
The Annals of Pharmacotherapy|February 22, 2020
Management of Mantle Cell Lymphoma in the Era of Novel Oral AgentsMichael J Buege, Anita Kumar, Brianne N Dixon, et al.
European Journal of Haematology|March 27, 2023
Low incidence of cardiotoxicity in patients with non-Hodgkin lymphoma receiving EPOCH after prior anthracycline exposureMichael J Buege, Esther Drill, Steven M Horwitz, et al.
Pageof 1